Acelyrin Statistics

Total Valuation

Acelyrin has a market cap or net worth of $227.15 million. The enterprise value is -$176.38 million.

Market Cap	227.15M
Enterprise Value	-176.38M

Important Dates

The last earnings date was Wednesday, May 14, 2025, after market close.

Earnings Date	May 14, 2025
Ex-Dividend Date	n/a

Share Statistics

Acelyrin has 100.95 million shares outstanding. The number of shares has increased by 11.59% in one year.

Current Share Class	100.95M
Shares Outstanding	100.95M
Shares Change (YoY)	+11.59%
Shares Change (QoQ)	+0.40%
Owned by Insiders (%)	3.11%
Owned by Institutions (%)	65.61%
Float	68.45M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.56
P/TBV Ratio	0.56
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 18.43, with a Debt / Equity ratio of 0.02.

Current Ratio	18.43
Quick Ratio	17.81
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -51.08% and return on invested capital (ROIC) is -31.91%.

Return on Equity (ROE)	-51.08%
Return on Assets (ROA)	-29.82%
Return on Invested Capital (ROIC)	-31.91%
Return on Capital Employed (ROCE)	-65.48%
Revenue Per Employee	n/a
Profits Per Employee	-$3.24M
Employee Count	83
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -47.67% in the last 52 weeks. The beta is 1.09, so Acelyrin's price volatility has been similar to the market average.

Beta (5Y)	1.09
52-Week Price Change	-47.67%
50-Day Moving Average	2.42
200-Day Moving Average	3.63
Relative Strength Index (RSI)	47.51
Average Volume (20 Days)	1,074,676

Short Selling Information

The latest short interest is 3.57 million, so 3.54% of the outstanding shares have been sold short.

Short Interest	3.57M
Short Previous Month	3.69M
Short % of Shares Out	3.54%
Short % of Float	5.21%
Short Ratio (days to cover)	3.80

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-270.55M
Pretax Income	-240.16M
Net Income	-268.52M
EBITDA	-270.06M
EBIT	-270.55M
Earnings Per Share (EPS)	-$2.69

Full Income Statement

Balance Sheet

The company has $410.59 million in cash and $7.07 million in debt, giving a net cash position of $403.52 million or $4.00 per share.

Cash & Cash Equivalents	410.59M
Total Debt	7.07M
Net Cash	403.52M
Net Cash Per Share	$4.00
Equity (Book Value)	407.23M
Book Value Per Share	4.04
Working Capital	406.19M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$285.58 million and capital expenditures -$1.19 million, giving a free cash flow of -$286.77 million.

Operating Cash Flow	-285.58M
Capital Expenditures	-1.19M
Free Cash Flow	-286.77M
FCF Per Share	-$2.84

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Acelyrin does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-11.59%
Shareholder Yield	-11.59%
Earnings Yield	-118.21%
FCF Yield	-126.25%

Analyst Forecast

The average price target for Acelyrin is $9.60, which is 326.67% higher than the current price. The consensus rating is "Hold".

Price Target	$9.60
Price Target Difference	326.67%
Analyst Consensus	Hold
Analyst Count	5
Revenue Growth Forecast (5Y)	29.71%
EPS Growth Forecast (5Y)	-29.07%

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1